Tower Research Capital »

Avita Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $22k 1.7k 12.80
2024-09-30 $16k 1.5k 10.72
2024-06-30 $40k 5.0k 7.92
2024-03-31 $4.0k 248 16.03
2023-09-30 $8.0k 548 14.64
2023-06-30 $11k 624 17.01
2022-12-31 $23k 3.5k 6.64
2022-09-30 $9.0k 1.6k 5.56
2022-06-30 $54k 11k 4.74
2022-03-31 $8.0k 978 8.18
2021-12-31 $20k 1.9k 10.42
2021-09-30 $57k 3.3k 17.59
2021-06-30 $22k 1.1k 20.39
2020-12-31 $11k 654 16.39
2020-09-30 $43k 1.7k 25.32
2020-06-30 $8.0k 276 28.99